Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
David W Brandes. (2010) The role of glatiramer acetate in the early treatment of multiple sclerosis. Neuropsychiatric Disease and Treatment 6, pages 329-336.
Read now
Read now
Clemens Warnke, Heinz Wiendl, Hans-Peter Hartung, Olaf Stüve & Bernd C Kieseier. (2010) Identification of targets and new developments in the treatment of multiple sclerosis – focus on cladribine. Drug Design, Development and Therapy 4, pages 117-126.
Read now
Read now
Demet Cicek, Basak Kandi, Sevilay Oguz, Bengu Cobanoglu, Serpil Bulut & Yunus Saral. (2008) An urticarial vasculitis case induced by glatiramer acetate. Journal of Dermatological Treatment 19:5, pages 305-307.
Read now
Read now
Articles from other publishers (16)
E.J. Ramos González, L.J. Ramirez Jirano, D.Z. García Martínez, G.G. Ortiz, L.F. Jave Suárez, C.A. Leal Cortes & O.K. Bitzer Quintero. (2021) A comparative study of melatonin and immunomodulatory therapy with interferon beta and glatiramer acetate in a mouse model of multiple sclerosis. Neurología (English Edition) 36:4, pages 262-270.
Crossref
Crossref
E.J. Ramos González, L.J. Ramirez Jirano, D.Z. García Martínez, G.G. Ortiz, L.F. Jave Suárez, C.A. Leal Cortes & O.K. Bitzer Quintero. (2021) Estudio comparativo de melatonina contra los tratamientos inmunomoduladores (interferón beta y acetato de glatirámero) en un modelo murino de esclerosis múltiple. Neurología 36:4, pages 262-270.
Crossref
Crossref
Christian Kleist, Elisabeth Mohr, Sadanand Gaikwad, Laura Dittmar, Stefanie Kuerten, Michael Platten, Walter Mier, Michael Schmitt, Gerhard Opelz & Peter Terness. (2016) Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis. Journal of Translational Medicine 14:1.
Crossref
Crossref
M. Twilt & S. M. Benseler. (2013) Childhood inflammatory brain diseases: pathogenesis, diagnosis and therapy. Rheumatology 53:8, pages 1359-1368.
Crossref
Crossref
Wahid Khan, Saravanan Muthupandian, Shady Farah, Neeraj Kumar & Abraham J. Domb. (2011) Biodegradable Polymers Derived From Amino Acids. Macromolecular Bioscience 11:12, pages 1625-1636.
Crossref
Crossref
Annette Baumgartner, Oliver Stich & Sebastian Rauer. (2011) Anaphylactic Reaction after Injection of Glatiramer Acetate (Copaxone®) in Patients with Relapsing-Remitting Multiple Sclerosis. European Neurology 66:6, pages 368-370.
Crossref
Crossref
Kewal K. JainKewal K. Jain. 2011. The Handbook of Neuroprotection. The Handbook of Neuroprotection
25
139
.
C. Warnke, V.I. Leussink, B.C. Kieseier & H.-P. Hartung. (2010) Interferon β bei Multipler SkleroseInterferon β for multiple sclerosis. Der Nervenarzt 81:12, pages 1476-1482.
Crossref
Crossref
Mikhail Soloviev. 2010. Peptidomics. Peptidomics
3
9
.
N De Stefano, M Filippi, C Confavreux, P Vermersch, M Simu, C Sindic, R Hupperts, O Bajenaru, G Edan, L Grimaldi, I Marginean, R Medaer, G Orefice, I Pascu, J Pelletier, E Sanders, E Scarpini & GL Mancardi. (2008) The results of two multicenter, open-label studies assessing efficacy, tolerability and safety of protiramer, a high molecular weight synthetic copolymeric mixture, in patients with relapsing–remitting multiple sclerosis. Multiple Sclerosis Journal 15:2, pages 238-243.
Crossref
Crossref
Jeffrey A. Cohen. (2009) The future of multiple sclerosis treatment. Journal of the Neurological Sciences 277, pages S55-S61.
Crossref
Crossref
Irena Lavrnja, Danijela Stojkov, Ivana Bjelobaba, Sanja Pekovic, Sanja Dacic, Nadezda Nedeljkovic, Marija Mostarica-Stojkovic, Stanislava Stosic-Grujicic, Ljubisav Rakic & Mirjana Stojiljkovic. (2008) Ribavirin ameliorates experimental autoimmune encephalomyelitis in rats and modulates cytokine production. International Immunopharmacology 8:9, pages 1282-1290.
Crossref
Crossref
Omar Khan, Yimin Shen, Fen Bao, Christina Caon, Alexandros Tselis, Zahid Latif & Imad Zak. (2008)
Long-Term Study of Brain
1
H-MRS Study in Multiple Sclerosis: Effect of Glatiramer Acetate Therapy on Axonal Metabolic Function and Feasibility of Long-Term
1
H-MRS Monitoring in Multiple Sclerosis
. Journal of Neuroimaging 18:3, pages 314-319.
Crossref
Crossref
Phillip G. Popovich & Erin E. Longbrake. (2008) Can the immune system be harnessed to repair the CNS?. Nature Reviews Neuroscience 9:6, pages 481-493.
Crossref
Crossref
Erin E. McCandless & Robyn S. Klein. (2007) Molecular targets for disrupting leukocyte trafficking during multiple sclerosis. Expert Reviews in Molecular Medicine 9:20, pages 1-19.
Crossref
Crossref
Shih-Jen Tsai. (2007) Glatiramer acetate could be a potential therapeutic agent for Parkinson’s disease through its neuroprotective and anti-inflammatory effects. Medical Hypotheses 69:6, pages 1219-1221.
Crossref
Crossref